Peer-reviewed veterinary case report
Research Progress on Adriamycin-Induced Myocardial Injury: Pathological Mechanism and Animal Model.
- Journal:
- Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
- Year:
- 2026
- Authors:
- Tao, Xuan-Yi et al.
- Affiliation:
- Department of Pharmacy · China
Abstract
Adriamycin is an anthracycline chemotherapy drug used in cancer treatment,and its cardiotoxicity primarily manifests as structural and functional damage to myocardial cells,which can lead to severe cardiovascular diseases such as heart failure.This article reviews recent advances in adriamycin-induced myocardial injury,focusing on its pathological mechanisms,potential therapeutic drugs,and commonly used animal models,to provide a research basis and intervention strategies for developing effective treatments.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41885157/